+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
DRAGARWQ DRAGARWQ

Dr. Agarwal's Eye Hospital Share Price

₹5,310.00 -5.75 (-0.11%)

11 Sep, 2026 4:01 PM (IST)

Dr. Agarwal's Eye Hospital live price: ₹5,310.00. It opened at ₹5,263 vs previous close ₹5,316; intraday high/low: ₹5,357/₹5,235. The 50 & 200 DMA stand at ₹5,217.40/₹5,024.30.

Dr. Agarwal's Eye Hospital Performance

  • Today's Low
  • ₹5,235
  • Today's High
  • ₹5,357
  • 52 Week Low
  • ₹4,412
  • 52 Week High
  • ₹6,392
  • Open Price₹5,263
  • Previous Close₹5,316
  • Volume1,166
  • 50 DMA₹5,217.40
  • 100 DMA₹5,128.00
  • 200 DMA₹5,024.30

Dr. Agarwal's Eye Hospital Chart

Investment Returns

  • Over 1 Month -1.17%
  • Over 3 Month + 7%
  • Over 6 Month + 8.35%
  • Over 1 Year + 14.27%

Smart Investing Starts Here Start SIP with Dr. Agarwal's Eye Hospital for Steady Growth!

Invest Now

Dr. Agarwal's Eye Hospital Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.7
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 2,496
  • P/B Ratio
  • 6.8
  • Average True Range
  • 146.4
  • EPS
  • 162.2
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 27.5
  • RSI
  • 52.05
  • MFI
  • 61.96

Latest Stock News Updates

Dr Agarwals Eye Hospital Ltd-$ - 526783 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

32nd Annual General Meeting (AGM)- Results of the remote e-voting and e-voting during the AGM along with the Scrutinizer report, is submitted.

Dr Agarwals Eye Hospital Ltd-$ - 526783 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Summary of proceedings of the 32nd Annual General Meeting of the Company held on September 09, 2026, is submitted.

Dr Agarwals Eye Hospital Ltd-$ - 526783 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Media Release - Launch of World''s first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.

Dr. Agarwal's Eye Hospital Financials

Dr. Agarwal's Eye Hospital Technicals

EMA & SMA

Current Price
₹5,310.00
-5.75 (-0.11%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹5,297.00
  • 50 Day
  • ₹5,217.40
  • 100 Day
  • ₹5,128.00
  • 200 Day
  • ₹5,024.30

Resistance and Support

5300.77 Pivot Speed
  • R3 5,487.80
  • R2 5,422.40
  • R1 5,366.20
  • S1 5,244.60
  • S2 5,179.10
  • S3 5,122.90

Dr. Agarwal's Eye Hospital Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-03 Quarterly Results
2026-05-20 Audited Results & Final Dividend
2026-02-03 Quarterly Results
2025-10-30 Quarterly Results & Interim Dividend
2025-08-27 Preferential Issue of shares
Date Purpose Remarks
2026-09-02 FINAL Rs.4.00 per share(40%)Final Dividend
2025-11-07 INTERIM Rs.3.00 per share(30%)Interim Dividend
2025-09-18 FINAL Rs.3.50 per share(35%)Final Dividend
2024-11-08 INTERIM Rs.2.50 per share(25%)Interim Dividend
2023-10-31 INTERIM Rs.2.50 per share(25%)Interim Dividend
View Dr. Agarwal's Eye Hospital Dividend History Arrow

Dr. Agarwal's Eye Hospital Shareholding Pattern

72.67%
23.03%
2.24%
2.02%
0.03%

About Dr. Agarwal's Eye Hospital

Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services. View More
  • NSE Symbol
  • DRAGARWQ
  • BSE Symbol
  • 526783
  • ISIN
  • INE934C01018

Similar Stocks to Dr. Agarwal's Eye Hospital

Dr. Agarwal's Eye Hospital FAQs

Dr. Agarwal's Eye Hospital share price is ₹5,310 As on 13 September, 2026 | 23:02

The Market Cap of Dr. Agarwal's Eye Hospital is ₹2495.7 Cr As on 13 September, 2026 | 23:02

The P/E ratio of Dr. Agarwal's Eye Hospital is 32.7 As on 13 September, 2026 | 23:02

The PB ratio of Dr. Agarwal's Eye Hospital is 6.8 As on 13 September, 2026 | 23:02

The 52 week High & Low of Dr. Agarwal's Eye Hospital is ₹6392/₹4412 respectively As on 13 September, 2026 | 23:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23